OSR Holdings, Inc.OSRHEarnings & Financial Report
Nasdaq · Health Care · Surgical & Medical Instruments & Apparatus
OSRH Q3 FY2025 Key Financial Metrics
Revenue
$627.7K
Gross Profit
$261.7K
Operating Profit
$-3.8M
Net Profit
$-3.2M
Gross Margin
41.7%
Operating Margin
-605.9%
Net Margin
-508.9%
YoY Growth
-23.7%
EPS
$0.12
OSR Holdings, Inc. Q3 FY2025 Financial Summary
OSR Holdings, Inc. reported revenue of $627.7K (down 23.7% YoY) for Q3 FY2025, with a net profit of $-3.2M (down 1283.3% YoY) (-508.9% margin). Cost of goods sold was $366.0K, operating expenses totaled $4.1M.
Key Financial Metrics
| Total Revenue | $627.7K |
|---|---|
| Net Profit | $-3.2M |
| Gross Margin | 41.7% |
| Operating Margin | -605.9% |
| Report Period | Q3 FY2025 |
OSR Holdings, Inc. Quarterly Revenue & Net Profit History
OSR Holdings, Inc. results over the last 6 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q3 FY2025 | $627.7K | -23.7% | $-3.2M | -508.9% |
| Q2 FY2025 | $1.1M | +28.8% | $-5.2M | -460.2% |
| Q1 FY2025 | $761.3K | -16.4% | $-11.4M | -1496.5% |
| Q3 FY2024 | $823.0K | — | $-231.0K | -28.1% |
| Q2 FY2024 | $881.8K | — | $-97.3K | -11.0% |
| Q1 FY2024 | $910.2K | — | $-60.4K | -6.6% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $910225 | $881829 | $822996 | $761272 | $1.1M | $627747 |
| YoY Growth | N/A | N/A | N/A | -16.4% | 28.8% | -23.7% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|
| Assets | $37.3M | $20.6M | $20.9M | $174.6M | $185.4M | $177.3M |
| Liabilities | $4.8M | $5.5M | $6.0M | $42.3M | $46.3M | $43.1M |
| Equity | $-4.3M | $-4.9M | $-5.8M | $132.3M | $139.2M | $134.2M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|
| Operating CF | $-498776 | $-483215 | $-686453 | $-64069 | $-482609 | $-2.7M |